Literature DB >> 26801953

Hypoglycemic Syndrome without Hyperinsulinemia. A Diagnostic Challenge.

Belén Pérez-Pevida1, Miguel Ángel Idoate2, Sara Fernández-Landázuri3, Nerea Varo3, Javier Escalada4.   

Abstract

The most common cause of organic fasting hypoglycemia in adults is the presence of an insulin-producing pancreatic adenoma, but when high insulin levels are not found, the differential diagnosis is challenging. Misdiagnosis can lead to an unnecessary pancreatectomy. Insulin concentrations may be low in some cases despite a clinical history suggestive of insulinoma. In these cases, a proinsulinoma should be suspected, although the rarity of this condition requires an extensive workup before reaching a final diagnosis. We describe an unusual case of a 38-year-old man with a severe hypoglycemic syndrome due to a proinsulin-secreting pancreatic adenoma. Insulin was measured by the specific assay and suppressed under the lower detection limit during fasting hypoglycemia. Serum proinsulin and C-peptide levels were abnormally elevated, and further tests revealed an islet cell tumor. The tumor was surgically removed, relieving the fasting hypoglycemia. Histopathological study showed a conventional well-differentiated neuroendocrine tumor with high immunoreactivity against proinsulin and with lesser intensity against insulin. Interestingly, GS-9A8 antibody clone used for immunostaining proinsulin did not cross-react with human insulin or C-peptide, providing an unbiased picture of proinsulin secretion. The resolution of symptoms, the fall of proinsulin concentrations after tumor removal and the histopathology study confirmed the diagnosis of proinsulinoma.

Entities:  

Keywords:  Hypoglycemic syndrome; Monoclonal antibody GS-9A8 against proinsulin; Neuroendocrine tumors; Proinsulin-producing pancreatic adenoma; Proinsulinoma

Mesh:

Substances:

Year:  2016        PMID: 26801953     DOI: 10.1007/s12022-016-9415-x

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  9 in total

1.  NANETS consensus guidelines for the diagnosis of neuroendocrine tumor.

Authors:  Aaron I Vinik; Eugene A Woltering; Richard R P Warner; Martyn Caplin; Thomas M O'Dorisio; Gregory A Wiseman; Domenico Coppola; Vay Liang W Go
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

2.  Possibilities of false immunocytochemical results generated by the use of monoclonal antibodies: the example of the anti-proinsulin antibody.

Authors:  M Bendayan
Journal:  J Histochem Cytochem       Date:  1995-09       Impact factor: 2.479

Review 3.  Insulinoma.

Authors:  Clive S Grant
Journal:  Best Pract Res Clin Gastroenterol       Date:  2005-10       Impact factor: 3.043

4.  Histochemistry, ultrastructure and hormone content of human insulinomas.

Authors:  W Creutzfeldt; C Creutzfeldt; H Frerichs; N S Track; R Arnold
Journal:  Horm Metab Res       Date:  1976       Impact factor: 2.936

Review 5.  Biochemistry of neuroendocrine tumours.

Authors:  Wouter W de Herder
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2007-03       Impact factor: 4.690

6.  The production and characterization of monoclonal antibodies specific for human proinsulin using a sensitive microdot assay procedure.

Authors:  O D Madsen; R M Cohen; F W Fitch; A H Rubenstein; D F Steiner
Journal:  Endocrinology       Date:  1983-12       Impact factor: 4.736

7.  The role of proinsulin and insulin in the diagnosis of insulinoma: a critical evaluation of the Endocrine Society clinical practice guideline.

Authors:  Jean-Marc Guettier; Andreea Lungu; Anne Goodling; Craig Cochran; Phillip Gorden
Journal:  J Clin Endocrinol Metab       Date:  2013-09-30       Impact factor: 5.958

Review 8.  Sporadically occurring functional pancreatic endocrine tumors: review of recent literature.

Authors:  Steven B Goldin; Jason Aston; Monika M Wahi
Journal:  Curr Opin Oncol       Date:  2008-01       Impact factor: 3.645

9.  Hypoglycemic syndrome in a patient with proinsulin-only secreting pancreatic adenoma (proinsulinoma).

Authors:  Gian Paolo Fadini; Alberto Maran; Anna Valerio; Francesco Meduri; Mariarosa Pelizzo; Diego Miotto; Cristiano Lanza; Giuseppe Altavilla; Angelo Avogaro
Journal:  Case Rep Med       Date:  2011-07-03
  9 in total
  4 in total

1.  Clinical and Laboratory Evaluation of a New Specific Point-of-Care Test for Intact Proinsulin.

Authors:  Andreas Pfützner; Anke H Pfützner; Peter H Kann; Gunther Burgard
Journal:  J Diabetes Sci Technol       Date:  2016-09-25

Review 2.  A Systematic Review of Proinsulin-Secreting Pancreatic Neuroendocrine Tumors.

Authors:  Timothy D Murtha; Beatrice C Lupsa; Sachin Majumdar; Dhanpat Jain; Ronald R Salem
Journal:  J Gastrointest Surg       Date:  2017-05-16       Impact factor: 3.452

3.  Proinsulin-Secreting Neuroendocrine Tumors of the Pancreas: A Single-Centre Experience.

Authors:  Andrey Germanovich Kriger; Stanislav Valer'evich Berelavichus; Ayrat Radikovich Kaldarov; Vladimir Igorevich Panteleev; David Semjonovich Gorin; Rimma Sangaevna Dugarova; Marina Yur'evna Yukina
Journal:  Gastrointest Tumors       Date:  2019-08-13

4.  Refractory spontaneous hypoglycaemia: a diagnostic conundrum

Authors:  Seong Keat Cheah; David Halsall; Peter Barker; John Grant; Abraham Mathews; Shyam Seshadri; Singhan Krishnan
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2018-09-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.